Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate

被引:15
|
作者
Sim, Ju-Ri [1 ,2 ]
Kang, Seok-Seong [3 ]
Lee, Daesang [4 ]
Yun, Cheol-Heui [5 ,6 ]
Han, Seung Hyun [1 ,2 ]
机构
[1] Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, DRI, Seoul, South Korea
[2] Seoul Natl Univ, Sch Dent, Plus Program BK21, Seoul, South Korea
[3] Dongguk Univ Seoul, Dept Food Sci & Biotechnol, Goyang, South Korea
[4] Agcy Def Dev, R&D Inst 5, Daejeon, South Korea
[5] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea
[6] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
新加坡国家研究基金会;
关键词
cholera vaccine; short-chain fatty acids; butyrate; chemokines; intestinal epithelial cells; HUMAN DENDRITIC CELLS; IMMUNE-RESPONSES; MUCOSAL IMMUNITY; STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTION; CHEMOKINE RECEPTOR; LIPOTEICHOIC ACID; EXTRACELLULAR ATP; CONTROLLED-TRIAL; VIBRIO-CHOLERAE;
D O I
10.3389/fimmu.2018.00055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, modulate immune responses in the gut. However, the effect of SCFAs on mucosal vaccine-induced immune cell migration is poorly understood. Here, we investigated whether SCFAs modulate chemokine expression induced by the killed whole-cell oral cholera vaccine, Shanchol (TM), in human intestinal epithelial cells. Shanchol (TM) induced expression of CCL2, CCL5, CCL20, and CXCL10 at the mRNA level, but not at the protein level. Interestingly, CCL20 secretion was substantially increased by co-stimulation with Shanchol (TM) and butyrate, while neither acetate nor propionate showed such effect. Enhanced CCL20 secretion was associated with GPR109A activation, and histone deacetylase (HDAC) inhibition. In addition, co-treatment with Shanchol (TM) and butyrate synergistically increased the secretion of adenosine triphosphate (ATP). Moreover, CCL20 secretion was decreased by inhibiting the extracellular ATP receptor P2X7. However, neither inflammasomes nor caspases were involved in CCL20 production. The culture supernatant of cells treated with Shanchol (TM) and butyrate augmented human immature dendritic cell migration. Collectively, these results suggest that butyrate enhances Shanchol (TM)-induced CCL20 production in human intestinal epithelial cells via HDAC inhibition and ATP-P2X7 signaling by activating GPR109A. These effects potentially enhance the mucosal immune responses in the gut induced by this oral cholera vaccine.
引用
收藏
页数:12
相关论文
共 5 条
  • [1] The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line
    Inan, MS
    Rasoulpour, RJ
    Yin, L
    Hubbard, AK
    Rosenberg, DW
    Giardina, C
    GASTROENTEROLOGY, 2000, 118 (04) : 724 - 734
  • [2] Microbiota metabolites short-chain fatty acid butyrate conditions intestinal epithelial cells to promote development of Treg cells and T cell IL-10 production
    Xu, Leiqi
    Ma, Chunyan
    Huang, Xiangsheng
    Yang, Wenjing
    Chen, Liang
    Bilotta, Anthony James
    Yao, Suxia
    Cong, Yingzi
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [3] Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Lines in vitro
    Asarat, M.
    Vasiljevic, T.
    Apostolopoulos, V.
    Donkor, O.
    IMMUNOLOGICAL INVESTIGATIONS, 2015, 44 (07) : 678 - 693
  • [4] Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells
    Bachmann, Malte
    Meissner, Carlotta
    Pfeilschifter, Josef
    Muehl, Heiko
    BIOFACTORS, 2017, 43 (02) : 283 - 292
  • [5] Pivanex, a short-chain fatty acid histone deacetylase inhibitor, induces changes in key regulatory protein expression in human non-small cell lung carcinoma cells.
    Sreedharan, SP
    Wirtz, UF
    Carrizales, G
    Sahai, R
    Revilla, M
    Izbicka, E
    Bucalo, L
    Valone, F
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6111S - 6112S